End-of-day quote
INDONESIA S.E.
06:00:00 2024-05-13 pm EDT
|
5-day change
|
1st Jan Change
|
1,070
IDR
|
0.00%
|
|
+4.90%
|
+5.42%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
72,960
|
95,760
|
118,526
|
249,480
|
766,080
|
316,680
|
Enterprise Value (EV)
1 |
160,160
|
165,069
|
123,323
|
213,101
|
732,082
|
285,834
|
P/E ratio
|
-10.7
x
|
35.8
x
|
1,453
x
|
32
x
|
81.8
x
|
16
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.5
x
|
0.72
x
|
1.24
x
|
1.99
x
|
4.29
x
|
1.26
x
|
EV / Revenue
|
1.09
x
|
1.23
x
|
1.29
x
|
1.7
x
|
4.1
x
|
1.14
x
|
EV / EBITDA
|
53.5
x
|
51.5
x
|
24.3
x
|
21.7
x
|
47.8
x
|
11
x
|
EV / FCF
|
-7.76
x
|
11.9
x
|
7.12
x
|
31.3
x
|
-120
x
|
-49.9
x
|
FCF Yield
|
-12.9%
|
8.38%
|
14%
|
3.2%
|
-0.83%
|
-2.01%
|
Price to Book
|
5.89
x
|
5.83
x
|
1.82
x
|
2.36
x
|
8.04
x
|
2.32
x
|
Nbr of stocks (in thousands)
|
152,000
|
152,000
|
249,005
|
252,000
|
252,000
|
312,000
|
Reference price
2 |
480.0
|
630.0
|
476.0
|
990.0
|
3,040
|
1,015
|
Announcement Date
|
5/3/19
|
3/31/20
|
6/25/21
|
4/28/22
|
4/10/23
|
4/16/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
147,156
|
133,908
|
95,688
|
125,324
|
178,584
|
250,993
|
EBITDA
1 |
2,991
|
3,203
|
5,071
|
9,826
|
15,304
|
25,907
|
EBIT
1 |
1,628
|
1,820
|
4,211
|
9,043
|
14,672
|
25,011
|
Operating Margin
|
1.11%
|
1.36%
|
4.4%
|
7.22%
|
8.22%
|
9.96%
|
Earnings before Tax (EBT)
1 |
-5,921
|
2,344
|
1,117
|
9,303
|
15,267
|
25,948
|
Net income
1 |
-6,814
|
2,672
|
49.81
|
7,806
|
11,593
|
19,810
|
Net margin
|
-4.63%
|
2%
|
0.05%
|
6.23%
|
6.49%
|
7.89%
|
EPS
2 |
-44.83
|
17.58
|
0.3277
|
30.97
|
37.16
|
63.49
|
Free Cash Flow
1 |
-20,650
|
13,839
|
17,310
|
6,810
|
-6,081
|
-5,732
|
FCF margin
|
-14.03%
|
10.33%
|
18.09%
|
5.43%
|
-3.41%
|
-2.28%
|
FCF Conversion (EBITDA)
|
-
|
432.11%
|
341.34%
|
69.31%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
517.9%
|
34,752.94%
|
87.25%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/3/19
|
3/31/20
|
6/25/21
|
4/28/22
|
4/10/23
|
4/16/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
87,200
|
69,309
|
4,797
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
36,379
|
33,998
|
30,846
|
Leverage (Debt/EBITDA)
|
29.15
x
|
21.64
x
|
0.946
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-20,650
|
13,839
|
17,310
|
6,810
|
-6,081
|
-5,732
|
ROE (net income / shareholders' equity)
|
-45%
|
18.6%
|
0.12%
|
9.14%
|
10.4%
|
15.6%
|
ROA (Net income/ Total Assets)
|
0.82%
|
0.94%
|
2.31%
|
4.83%
|
6.98%
|
10.3%
|
Assets
1 |
-828,930
|
284,989
|
2,156
|
161,650
|
166,085
|
191,868
|
Book Value Per Share
2 |
81.50
|
108.0
|
261.0
|
420.0
|
378.0
|
438.0
|
Cash Flow per Share
2 |
69.20
|
79.80
|
112.0
|
144.0
|
109.0
|
98.90
|
Capex
1 |
150
|
163
|
448
|
-
|
1,226
|
2,699
|
Capex / Sales
|
0.1%
|
0.12%
|
0.47%
|
-
|
0.69%
|
1.08%
|
Announcement Date
|
5/3/19
|
3/31/20
|
6/25/21
|
4/28/22
|
4/10/23
|
4/16/24
|
|
1st Jan change
|
Capi.
|
---|
| +5.42% | 20.92M | | +5.41% | 106B | | -4.19% | 64.74B | | +73.33% | 49.34B | | +17.24% | 39.15B | | +6.13% | 32.86B | | +12.77% | 20.29B | | +15.03% | 17.21B | | +19.06% | 15.28B | | +6.28% | 14.58B |
Other Commodity Chemicals
|